This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Statistics and Research Methods  • Hypertension  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The CAMELOT study by Dr Nissen and colleagues¹ found that while hard end points, defined as cardiovascular death or nonfatal myocardial infarction, were not different among the 3 study groups, amlodipine was more effective than enalapril or placebo at preventing soft end points such as hospitalization for angina. Among 4 large clinical trials that evaluated long-term risk reduction with the use of angiotensin-converting enzyme inhibitors in patients with angina,^1-4 the results of CAMELOT are consistent with the Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) trial but in contrast with the Heart Outcomes Prevention Evaluation (HOPE) trial and the European Trial on Reduction of Cardiac Events With Perindopril in Stable Coronary Artery Disease (EUROPA), which showed beneficial effects of angiotensin-converting enzyme inhibition. Of these studies, the CAMELOT patient population may consist of the lowest-risk group since the prevalence of prior myocardial infarction was less than 40%, . . . [Full Text of this Article]

Taishiro Chikamori, MD
chikamd@tokyo-med.ac.jp

Hirofumi Tomiyama, MD; Akira Yamashina, MD
Department of Internal Medicine II/Cardiology
Tokyo Medical University
Tokyo, Japan

RELATED ARTICLES

Antihypertensive Agents and Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure
Victor Aboyans, Philippe Lacroix, and Claude Cassat
JAMA. 2005;293(10):1187.
EXTRACT | FULL TEXT  

Antihypertensive Agents and Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure
Luca Mascitelli and Francesca Pezzetta
JAMA. 2005;293(10):1188.
EXTRACT | FULL TEXT  

Antihypertensive Agents and Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure—Reply
Steven E. Nissen and For the CAMELOT Investigators
JAMA. 2005;293(10):1188-1189.
EXTRACT | FULL TEXT  

Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure: The CAMELOT Study: A Randomized Controlled Trial
Steven E. Nissen, E. Murat Tuzcu, Peter Libby, Paul D. Thompson, Magdi Ghali, Dahlia Garza, Lance Berman, Harry Shi, Ethel Buebendorf, Eric J. Topol, and for the CAMELOT Investigators
JAMA. 2004;292(18):2217-2225.
ABSTRACT | FULL TEXT